article thumbnailA dramatic decline in smoking rates has coincided with the introduction of plain-packaging laws in Australia. The daily smoking rate decreased from 15.1 per cent to 12.8 per cent between 2010 and 2013, according to the largest and longest-running national survey on drug statistics. Most people are now 16 before they smoke their...
article thumbnailAn exciting new project has been launched by IPPOSI and UCD in an attempt to solve some of the everyday problems that people with medical conditions encounter.  Are you interested in partnering with a healthcare technology company for one day to find a solution to an issue or dilemma that frustrates people with the same or...
National Rare Disease Plan Launch
Thursday, July 17th 2014 16:01
article thumbnailThe National Rare Disease Plan 2014 - 2018, published this month, outlines proposals for a new clinical care programme specifically for the treatment of rare diseases, which affect an estimated 6 to 8 per cent of people in their lifetime. Illnesses which affect fewer than five people in every 10,000 are considered “rare...
The Burden of COPD
Monday, July 7th 2014 16:16
article thumbnailEuropean Respiratory Society (ERS) Vice President Professor Jorgen Vestbo together with leading experts examine the current and future burden of chronic obstructive pulmonary disease (COPD) in this excellent video.         Alpha-1 antitrypsin deficiency is the most common genetic cause of COPD. The European Respiratory Society...
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test. 
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, along with cystic fibrosis, is the commonest genetic lung disease in Ireland. It severely affects more than 12,000 people, with another 170,000 carriers also at risk of lung and liver disease. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
Go to top